Peter Borchmann

Academic History

Peter Borchmann, MD, is Assistant Medical Director in the Department of Hematology and Oncology at University Hospital Cologne, Cologne, Germany, where he leads the lymphoma program and the Phase I/II CAR T-cell therapy unit. He also heads the certified center for hematological malignancies at the same institution. Prof. Borchmann currently serves as Co-Chairman of the German Hodgkin Study Group (GHSG), where he oversees the design and execution of investigator-initiated clinical trials. He is a member of the German Society for Hematology and Oncology (DGHO), the European Hematology Association (EHA), and the American Society of Hematology (ASH).

Speaking on Hodgkin lymphoma and immunotherapeutic strategies

Prof. Borchmann specializes in the clinical management and trial-based investigation of Hodgkin and non-Hodgkin lymphomas, with a focus on immunotherapy, CAR T-cell strategies, and the treatment of elderly or frail patients. His work has contributed to redefining treatment protocols for relapsed or refractory lymphomas and advancing the role of PET-guided therapy.